UNION CITY, Calif.--(BUSINESS WIRE)--Celltheon today announced the commercial launch of its CHO-K1 based OmniCHO™ Transient Expression Kit, a breakthrough technology poised to transform preclinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback